Alterity Therapeutics annual capital expenditures (capex)
2016
2017
2018
2019
2020
2021
2022
2023
2024
Alterity Therapeutics Capital Expenditures (CapEx) Growth & History (ATHE)
Alterity Therapeutics's capital expenditures (capex) was $5,722 for fiscal 2024.
View full Alterity Therapeutics company overviewAlterity Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-06-30 | $5,722 | −$1,589 | −21.73% |
| 2023 | 2023-06-30 | $7,311 | −$81,836 | −91.80% |
| 2022 | 2022-06-30 | $89,147 | $78,675 | +751.29% |
| 2021 | 2021-06-30 | $10,472 | −$6,272 | −37.46% |
| 2020 | 2020-06-30 | $16,744 | $9,722 | +138.45% |
| 2019 | 2019-06-30 | $7,022 | −$55,383 | −88.75% |
| 2018 | 2018-06-30 | $62,405 | $34,487 | +123.53% |
| 2017 | 2017-06-30 | $27,918 | $25,611 | +1110.14% |
| 2016 | 2016-06-30 | $2,307 | — | — |
Alterity Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Alterity Therapeutics's capital expenditures (capex) decreased from $7,022 to $5,722, a change of −$1,300.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alterity Therapeutics source filings ↗